Literature DB >> 8990600

Evaluation of beta-endorphin secretion in patients suffering from episodic cluster headache.

R Franceschini1, M Leandri, M V Gianelli, A Cataldi, E Bruno, E Rolandi, T Barreca.   

Abstract

In order to obtain data regarding peripheral levels of beta-endorphin in head pain syndromes, we evaluated the plasma beta-endorphin secretory pattern in 12 adult male patients suffering from cluster headache. Blood samples were drawn every 2 hours for a 24-hour period, and in addition at 30-minute intervals for 120 minutes during cluster attacks. The same sampling was repeated during an asymptomatic period. Cluster headache patients showed no significant beta-endorphin circadian rhythm and a delayed acrophase during cluster periods compared with that recorded in the remission period and in normal subjects. Eighteen cluster headache attacks were recorded during the study day, 13 (72%) of which were followed by a significant increase in beta-endorphin levels. No correlation was found between beta-endorphin maximum net increase and intensity and/or duration of pain. These data suggest the hypothesis of a temporary alteration of beta-endorphin circadian secretion, probably related to involvement of neural structures controlling biorhythm pacemakers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8990600     DOI: 10.1046/j.1526-4610.1996.3610603.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Successful prophylactic treatment of chronic cluster headache with low-dose levomethadone.

Authors:  T Sprenger; C L Seifert; M Miederer; M Valet; T R Tölle
Journal:  J Neurol       Date:  2008-08-04       Impact factor: 4.849

Review 2.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 3.  [Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].

Authors:  T Sprenger; G Henriksen; M Valet; S Platzer; A Berthele; T R Tölle
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.